Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS

NCT06046287 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT06046287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS
Lead sponsor
Georgetown University
Phase
Phase 2
Overall status
Withdrawn
Start date
September 26, 2025
Completion date
September 26, 2025
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy of undetermined significance, peripheral neuropathy